This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Article: Drop In Cancer After Closure Of California Reactor Shows Need For Full Review Of Low-level Radiation Risks


Epidemiologist Joseph Mangano, MPH MBA, is the executive director of the Radiation and Public Health Project.  He is the author or co-author of 30 peer-reviewed medical journal articles and letters, and author of the books, Low Level Radiation and Immune System Disease: An Atomic Era Legacy (1998); Radioactive Baby Teeth: The Cancer Link (2008); and Mad Science: The Nuclear Power Experiment (2012).

Janette Sherman, MD, is an internist and toxicologist, and a former adjunct professor at Western Michigan University.  She is the author/co-author of many scientific publications, and is author of the books Chemical Exposure and Disease: Diagnostic and Investigative Techniques (1994) and Life's Delicate Balance: Causes and Prevention of Breast Cancer (2008).  She was the recipient of the 2006 Foremothers Award from The National Research Center for Women and Families.

EDITOR'S NOTE:   A streaming audio replay of a related news event will be available on the Web at as of 5 p.m. EDT/ 2 p.m. PDT on March 28, 2013.

SOURCE Epidemiologist Joseph Mangano, MPH MBA, executive director, Radiation and Public Health Project; Internist and toxicologist Janette Sherman, MD, adjunct professor, Western Michigan University

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $94.02 -2.67%
FB $104.07 -5.81%
GOOG $683.57 -3.45%
TSLA $162.60 -7.26%
YHOO $27.97 -4.05%


Chart of I:DJI
DOW 16,204.97 -211.61 -1.29%
S&P 500 1,880.05 -35.40 -1.85%
NASDAQ 4,363.1440 -146.4150 -3.25%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs